Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Anti-PAD4 autoantibodies as clinical response biomarkers for the treatment of rheumatoid arthritis

Anti-PAD4 autoantibodies as clinical response biomarkers for the treatment of rheumatoid arthritis

US Patent 11613580 · Granted Mar 28, 2023

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Anti-B7-H1 antibodies for treating tumors2023
Anti-B7-H1 antibodies for treating tumors2023
Polynucleotides encoding IL33 antibodies and methods of using the same2023
Genetic polymorphisms associated with cardiovascular disorders and drug response2023
Computer system with computing devices, communication device, task processing de2023
Task processing method applied to network topology, electronic device and storag2023
CCL20 as a predictor of clinical response to IL23-antagonists2022
CCL20 as a predictor of clinical response to IL23-antagonists2022
Prediction of clinical response to IL23-antagonists using IL23 pathway biomarker2021
Prediction of clinical response to IL23-antagonists using IL23 pathway biomarker2021
Genetic polymorphisms associated with cardiovascular disorders and drug response2021
Anti-B7-H1 antibodies for treating tumors2020